ADARx Pharmaceuticals, Inc. (ADRX)
12.67
-1.49
(-10.52%)
USD |
NASDAQ |
Nov 20, 15:59
ADARx Pharmaceuticals Price : 12.67 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 12.82 | 14.32 | 12.58 | 14.16 | 556343.0 |
| Nov 18, 2026 | 13.85 | 14.84 | 12.76 | 12.82 | 654563.0 |
| Nov 17, 2026 | 14.03 | 14.96 | 12.90 | 13.82 | 696893.0 |
| Nov 16, 2026 | 14.22 | 15.21 | 13.08 | 14.00 | 667016.0 |
| Nov 13, 2026 | 14.96 | 16.17 | 13.70 | 14.20 | 587961.0 |
| Nov 12, 2026 | 13.25 | 16.24 | 12.87 | 14.91 | 994943.0 |
| Nov 11, 2026 | 13.73 | 14.07 | 13.17 | 13.30 | 509964.0 |
| Nov 10, 2026 | 13.64 | 14.30 | 13.30 | 13.57 | 289837.0 |
| Nov 09, 2026 | 13.24 | 13.99 | 12.70 | 13.80 | 357034.0 |
| Nov 06, 2026 | 13.73 | 13.73 | 12.50 | 13.23 | 440018.0 |
| Nov 05, 2026 | 14.97 | 15.39 | 12.75 | 13.29 | 781164.0 |
| Nov 04, 2026 | 16.33 | 16.72 | 14.84 | 14.96 | 377837.0 |
| Nov 03, 2026 | 15.78 | 16.46 | 15.00 | 16.09 | 378483.0 |
| Nov 02, 2026 | 16.95 | 17.03 | 15.71 | 15.76 | 378676.0 |
| Oct 30, 2026 | 18.10 | 18.10 | 16.30 | 17.00 | 542259.0 |
| Oct 29, 2026 | 18.00 | 18.75 | 17.65 | 17.85 | 402002.0 |
| Oct 28, 2026 | 18.22 | 18.36 | 17.66 | 17.95 | 264652.0 |
| Oct 27, 2026 | 17.99 | 18.80 | 17.71 | 18.13 | 293664.0 |
| Oct 26, 2026 | 17.77 | 19.07 | 17.50 | 17.81 | 99579.00 |
| Oct 23, 2026 | 17.68 | 18.32 | 17.00 | 17.63 | 177568.0 |
| Oct 22, 2026 | 17.18 | 17.88 | 17.18 | 17.68 | 181463.0 |
| Oct 21, 2026 | 17.58 | 18.17 | 17.00 | 17.13 | 441573.0 |
| Oct 20, 2026 | 17.98 | 18.55 | 16.61 | 17.68 | 1.075M |
| Oct 19, 2026 | 17.76 | 18.32 | 17.05 | 17.63 | 262029.0 |
| Oct 16, 2026 | 17.73 | 18.60 | 17.50 | 17.65 | 247130.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Korsana Biosciences, Inc. | 37.33 |
| IRulya Therapeutics, Inc. | 39.93 |
| PepGen Inc. | 3.74 |
| Q32 Bio, Inc. | 8.35 |
| Bridgebio Oncology Therapeutics, Inc. | 1.815 |
Price Related Metrics
| PS Ratio | 255.06 |
| PEG Ratio | -0.0273 |
| Price to Book Value | 2.366 |
| Price to Free Cash Flow | 5.763 |
| Earnings Yield | -7.09% |
| Market Cap | 1.359B |
| PEGY Ratio | -0.0273 |